| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.26 | 0.09 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.18 | 0.09 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |